NCT01187186View on ClinicalTrials.gov

A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Liver Disease
Interventions
DRUG

ASP1941

oral

Trial Locations (1)

33014

Miami

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY